125 related articles for article (PubMed ID: 8980773)
21. The Pneumocystis carinii drug target S-adenosyl-L-methionine:sterol C-24 methyl transferase has a unique substrate preference.
Kaneshiro ES; Rosenfeld JA; Basselin-Eiweida M; Stringer JR; Keely SP; Smulian AG; Giner JL
Mol Microbiol; 2002 May; 44(4):989-99. PubMed ID: 12010494
[TBL] [Abstract][Full Text] [Related]
22. The activity of nitrofurazone and furazolidone against Leishmania donovani, L. major and L. enriettii in vitro and in vivo.
Neal RA; van Bueren J; Hooper G
Ann Trop Med Parasitol; 1988 Oct; 82(5):453-6. PubMed ID: 2855778
[TBL] [Abstract][Full Text] [Related]
23. Leishmania donovani Parasites Are Inhibited by the Benzoxaborole AN2690 Targeting Leucyl-tRNA Synthetase.
Manhas R; Tandon S; Sen SS; Tiwari N; Munde M; Madhubala R
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941647
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
[TBL] [Abstract][Full Text] [Related]
25. Differentiation and limited proliferation of isolated Leishmania mexicana amastigotes at 27 degrees C.
Taylor DR; Williams GT
Acta Trop; 1991 Dec; 50(2):141-50. PubMed ID: 1685870
[TBL] [Abstract][Full Text] [Related]
26. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
[TBL] [Abstract][Full Text] [Related]
27. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
[TBL] [Abstract][Full Text] [Related]
28. Pneumocystis carinii pneumonia: the status of Pneumocystis biochemistry.
Kaneshiro ES
Int J Parasitol; 1998 Jan; 28(1):65-84. PubMed ID: 9504336
[TBL] [Abstract][Full Text] [Related]
29. Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats.
Chen F; Cushion MT
J Clin Microbiol; 1994 Nov; 32(11):2791-800. PubMed ID: 7852574
[TBL] [Abstract][Full Text] [Related]
30. Oxidosqualene cyclase inhibitors as antimicrobial agents.
Hinshaw JC; Suh DY; Garnier P; Buckner FS; Eastman RT; Matsuda SP; Joubert BM; Coppens I; Joiner KA; Merali S; Nash TE; Prestwich GD
J Med Chem; 2003 Sep; 46(20):4240-3. PubMed ID: 13678402
[TBL] [Abstract][Full Text] [Related]
31. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
[TBL] [Abstract][Full Text] [Related]
32. Antileishmanial effects of clofazimine and other antimycobacterial agents.
Evans AT; Croft SL; Peters W; Neal RA
Ann Trop Med Parasitol; 1989 Oct; 83(5):447-54. PubMed ID: 2619361
[TBL] [Abstract][Full Text] [Related]
33. Status of respiration and ATP content in arsenite resistant Leishmania mexicana amazonensis.
Singh AK; Lee ST
Microb Pathog; 1999 Mar; 26(3):171-4. PubMed ID: 10089157
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of Tridax procumbens against promastigotes of Leishmania mexicana.
Martín-Quintal Z; Moo-Puc R; González-Salazar F; Chan-Bacab MJ; Torres-Tapia LW; Peraza-Sánchez SR
J Ethnopharmacol; 2009 Apr; 122(3):463-7. PubMed ID: 19429313
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive and definitive structural identities of Pneumocystis carinii sterols.
Giner JL; Zhao H; Beach DH; Parish EJ; Jayasimhulu K; Kaneshiro ES
J Lipid Res; 2002 Jul; 43(7):1114-24. PubMed ID: 12091496
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 2-substituted trifluoromethylquinolines for the evaluation of leishmanicidal activity.
Dade J; Provot O; Moskowitz H; Mayrargue J; Prina E
Chem Pharm Bull (Tokyo); 2001 Apr; 49(4):480-3. PubMed ID: 11310679
[TBL] [Abstract][Full Text] [Related]
37. Phosphomonoesterases of Leishmania mexicana mexicana and other flagellates.
Hassan HF; Coombs GH
Mol Biochem Parasitol; 1987 Apr; 23(3):285-96. PubMed ID: 3037369
[TBL] [Abstract][Full Text] [Related]
38. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.
Daneshvar H; Coombs GH; Hagan P; Phillips RS
J Infect Dis; 2003 May; 187(10):1662-8. PubMed ID: 12721947
[TBL] [Abstract][Full Text] [Related]
39. Purification, characterization, and drug susceptibility of tubulin from Leishmania.
Werbovetz KA; Brendle JJ; Sackett DL
Mol Biochem Parasitol; 1999 Jan; 98(1):53-65. PubMed ID: 10029309
[TBL] [Abstract][Full Text] [Related]
40. Members of a unique histidine acid phosphatase family are conserved amongst a group of primitive eukaryotic human pathogens.
Shakarian AM; Joshi MB; Yamage M; Ellis SL; Debrabant A; Dwyer DM
Mol Cell Biochem; 2003 Mar; 245(1-2):31-41. PubMed ID: 12708742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
